Cubist Pharmaceuticals, Inc. (CBST) Posts Q4 EPS of 66c
CBST Hot Sheet
EPS Growth %: -18.2%Financial Fact:
Total other income (expense), net: -8.51M
Today's EPS Names:
TARO, BRLI, TLB, More
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) reported Q4 EPS of $0.66, $0.34 better than the analyst estimate of $0.32. Revenue for the quarter came in at $213 million versus the consensus estimate of $204.74 million.
For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- UPDATE: Youku.com (YOKU) Misses Q1 EPS by 1c; Sees Q2 Sales Up 90-100% YoY
- UPDATE: Auriga Starts Teva Pharma (TEVA) at Hold; Sidelined Until New CEO Is Convincing
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
